It's usually a 1 year turnaround. So the approval should be in Q4 2011.
As for the directors selling, tax reasons would be the most likely response. Given their tax year ends Dec 31st. Otherwise there has no been any selling.
The Thoratec investment presentation from Q4 2010 showed some concern about their growth...which I suspect is directly related to Heartware's development.
It's usually a 1 year turnaround. So the approval should be in...
Add to My Watchlist
What is My Watchlist?